Marcus Clark is an expert in the field of Rheumatology. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He has 2 awards "Elected Member" and "Super Doctor". Marcus Clark is also published. He has 32 publications published. The lastest publication: "Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis.' Marcus Clark accepts Medicare payments and is listed with Medicare.gov.